title: Colon cancer after infliximab therapy for Crohn's disease in a young patient transplanted for primary sclerosing cholangitis.
authors.forename: Laurent
authors.initials: L
authors.lastname: Peyrin-Biroulet
authors.forename: Aude
authors.initials: A
authors.lastname: Bressenot
authors.forename: Laurence
authors.initials: L
authors.lastname: Chone
authors.forename: Philippe
authors.initials: P
authors.lastname: Denjean
authors.forename: Patrick
authors.initials: P
authors.lastname: Boissel
authors.forename: Marc-André
authors.initials: MA
authors.lastname: Bigard
authors.forename: Jean-Pierre
authors.initials: JP
authors.lastname: Bronowicki
mesh_terms: D000230:Adenocarcinoma / Q000139:chemically induced*; D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D002430:Cecal Neoplasms / Q000139:chemically induced; D015209:Cholangitis, Sclerosing / Q000601:surgery*; D003110:Colonic Neoplasms / Q000139:chemically induced*; D003424:Crohn Disease / Q000188:drug therapy*; D005765:Gastrointestinal Agents / Q000009:adverse effects*; D006801:Humans; D000069285:Infliximab; D016031:Liver Transplantation; D008297:Male; D011183:Postoperative Complications
chemical_list: D000911:Antibodies, Monoclonal; D005765:Gastrointestinal Agents; D000069285:Infliximab